Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.
about
Anti-endotoxin vaccines: back to the futureAntithrombin III for critically ill patientsAntithrombin III for critically ill patientsAntithrombin III for critically ill patientsPolyphosphate and omptins: novel bacterial procoagulant agentsSurviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cellsThe limitations of observational studies on the treatment of severe sepsisAntithrombin III in patients admitted to intensive care units: a multicenter observational study.Science review: role of coagulation protease cascades in sepsisBench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction?Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsisBench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsisRecently published papers: curing, caring and follow-upToll-like receptors: the key to the stable door?Looking beyond 28-day all-cause mortality.Paper reports overview: Cranberry juice, fluid replacement and bad innovationsPaper reports overview: Sepsis, insulin and noninvasive ventilation22nd International Symposium on Intensive Care and Emergency Medicine, Brussels, Belgium, 19-22 March 2002Brazilian Sepsis Epidemiological Study (BASES study)Quality of life effects of antithrombin III in sepsis survivors: results from the KyberSept trial [ISRCTN22931023]Clinical review: Drotrecogin alfa (activated) as adjunctive therapy for severe sepsis--practical aspects at the bedside and patient identificationCoagulation in sepsis: all bugs bite equallyDrotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies.Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation.Sepsis and disseminated intravascular coagulationNebulized heparin for patients under mechanical ventilation: an individual patient data meta-analysisAntithrombin in the treatment of burn traumaHost innate immune responses to sepsisCauses and consequences of coagulation activation in sepsis: an evolutionary medicine perspectivePAMPs and DAMPs as triggers for DICSepsis and ARDS: The Dark Side of HistonesPlatelets and coagulation in infectionCoagulation abnormalities in critically ill patientsA recombinant fragment of von Willebrand factor reduces fibrin-rich microthrombi formation in mice with endotoxemiaPost-marketing surveillance data of thrombomodulin alfa: sub-analysis in patients with sepsis-induced disseminated intravascular coagulation.New and emerging therapies for sepsis.Antithrombin significantly influences platelet adhesion onto immobilized fibrinogen in an in-vitro system simulating low flowHemodynamic goals in randomized clinical trials in patients with sepsis: a systematic review of the literature.Anticoagulant failure in coagulopathic patients: PTT confounding and other pitfalls.
P2860
Q22305428-B28D90AB-5E49-4AB7-8002-7C050FC8AE1FQ24186159-A5C1BB96-121A-42FF-96B5-5C17C92F2496Q24242053-89080431-7BAC-426E-855F-B624BD02C1B7Q24246826-42F6B5BE-2A6E-433D-BE51-7714F87333D5Q24629548-6DC6FAF2-7186-4FE9-B660-BB50FE523CD1Q24644984-BD095977-199D-4B2B-A744-09A2CB4E8153Q24646845-15942AD4-FD2F-4660-ABC3-33045A06FE24Q24791014-85219996-5A97-419B-B31F-881308B62B44Q24792729-0C8365E2-9CC4-4BF0-9C5E-0AD3CAB1D69CQ24794146-732DA2F7-F3A0-4CFF-AA87-F351B5350668Q24794238-A73369A5-E4A2-46B8-AE7C-7A3C5FE7ED2FQ24794551-C80489CD-BBF7-412B-8096-BC2DAB0CEE4AQ24794692-49F92FD8-8494-4C44-AC41-A28C2593B961Q24796218-6BD56435-8496-46AD-890D-09605FE64392Q24796709-A5D182DD-2B05-431A-8DD9-5A53280B3C08Q24796879-678056AA-D80E-45C4-830D-DE30D546DD32Q24797886-9DF4DFF1-7E02-461A-8787-B1F7D66D6CDCQ24798270-BA98E47B-D028-4610-A3D6-5A64B6C2B75EQ24798640-0C76BE08-1B74-46CE-9A2A-1234C9933986Q24801014-FAC78B1F-A4C7-4D65-9850-9233330E5753Q24801537-5D8106FA-D600-4C8B-B625-8DB1C83A8597Q24801879-107DA5F8-1BA2-4388-B760-A2055ECC15F2Q24805503-D8670BAC-F231-4EB9-9241-7D5D0CCC71D9Q24810495-8637F6FA-A72F-46D4-B64F-F6505308D1ECQ25255548-4687A6E2-9CF0-4D41-9897-A45F253FBCE8Q26751555-560CDD9F-AB74-4C25-A87B-BE25A3BB2AACQ26753103-6DCF3283-CCB3-499B-A591-E558E410D4BCQ26768246-27020805-D5FB-45D1-BE5A-E05A15F0C9A3Q26864635-AE86DD5B-5873-49BE-8708-B9639F2E6AC3Q26995417-1676A314-B6D4-4C8E-92DF-08729D184F89Q27013790-D934AC87-0F31-49CD-9A93-311A490F95E1Q27027282-04E9C46F-9936-44D7-9B05-C114FC50CFF4Q28079908-7940CDA7-524D-4CEA-A7CF-A18E763C5A9EQ28199912-5BEDFD6E-D04A-49F7-83F8-0BA52C73CDBDQ30836660-26F7AD41-43EC-4D5F-B049-F27247315338Q30880390-1E0E94FE-81C2-4C1D-85A9-F6739211CFCDQ33183531-6A572497-ED4B-46AF-9049-D69BA9BD45C2Q33260377-BB8989F3-2887-41D0-8847-0DA8A88A7669Q33288475-478FA9C4-9980-40EB-A3BA-1AEC83C5A105Q33409966-BD64048E-6721-4D4D-865C-CE8B854D437D
P2860
Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Caring for the critically ill ...... a randomized controlled trial.
@ast
Caring for the critically ill ...... a randomized controlled trial.
@en
Caring for the critically ill ...... a randomized controlled trial.
@nl
type
label
Caring for the critically ill ...... a randomized controlled trial.
@ast
Caring for the critically ill ...... a randomized controlled trial.
@en
Caring for the critically ill ...... a randomized controlled trial.
@nl
prefLabel
Caring for the critically ill ...... a randomized controlled trial.
@ast
Caring for the critically ill ...... a randomized controlled trial.
@en
Caring for the critically ill ...... a randomized controlled trial.
@nl
P2093
P356
P1476
Caring for the critically ill ...... a randomized controlled trial.
@en
P2093
A Atherstone
B L Warren
F Schindel
H Heinrichs
H O Keinecke
KyberSept Trial Study Group
P304
P356
10.1001/JAMA.286.15.1869
P407
P577
2001-10-01T00:00:00Z